Grundinformationen
- Standard-SMILES
CO[C@@]1(NC(=O)CSC(F)F)C(=O)N2C(C(=O)O)=C(CSc3nnnn3CCO)CO[C@@H]21- InChIKey
UHRBTBZOWWGKMK-DOMZBBRYSA-N- Summenformel
- C15H18F2N6O7S2
- Durchschnittliche Molmasse
- 496,5 g/mol
- Monoisotopische Masse
- 496,06464536
Überblick
Flomoxef is a second-generation oxacephem antibiotic in which the oxazine ring is substituted at C-3 with a hydroxyethyl-substituted tetrazolylthiomethyl group and the azetidinone ring carries 7alpha-methoxy and 7beta-{2-[(difluoromethyl)thiomethyl]acetamido} substituents. It has a role as an antibacterial drug. It is an organonitrogen heterocyclic antibiotic, a N-acyl-amino acid and an oxacephem.
Namen und Bezeichner
- Bevorzugter Name
- Flomoxef
- IUPAC
- (6R,7R)-7-[[2-(difluoromethylsulfanyl)acetyl]amino]-3-[[1-(2-hydroxyethyl)tetrazol-5-yl]sulfanylmethyl]-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- Englischer Name
- Flomoxef
- Summenformel
- C15H18F2N6O7S2
- Molmasse
- 496.47
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
99665-00-6- PubChem CID
- 65864
- DTXSID
DTXSID5048845- ChEMBL
CHEMBL15413- ChEBI
CHEBI:135813- UNII
- V9E5U5XF42
- Nikkaji
- J37.274I
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- -1,3
- Polarare Oberfläche (TPSA)
- 220 Ų
- H-Brücken-Donoren
- 3
- H-Brücken-Akzeptoren
- 14
- Frei drehbare Bindungen
- 11
- Schwere Atome
- 32
- Formalladung
- 0
- Komplexität
- 793
Experimentelle und physikochemische Eigenschaften
Drugs
Pharmaceuticals -> Anti infectives for systemic use -> Antibacterials for systemic use
Pharmaceuticals -> Listed in ZINC15
Pharmaceuticals -> Antibiotics
Physikochemische Eigenschaften
- Schmelzpunkt
- 82.5 · 82.5-87.5°
- Dichte
- 1.85 · 1.85±0.1 g/cm3(Predicted)
- storage temp.
- -20 °C · Store at -20°C
- Löslichkeit
- soluble in DMSO, Methanol
- Aggregatzustand
- Solid
- pka
- 3.26 · 3.26±0.40(Predicted)
- Farbe
- Off-White
- InChIKey
- UHRBTBZOWWGKMK-DOMZBBRYSA-N
- SMILES
- N12[C@@]([H])([C@@](NC(CSC(F)F)=O)(OC)C1=O)OCC(CSC1N(CCO)N=NN=1)=C2C(O)=O
- CAS Datenbank
- 99665 · 99665-00-6(CAS DataBase Reference)
Sicherheit und Regulatorisches
Toxikologische Informationen
Drug Induced Liver Injury
Drug-Induced Liver Injury Severity and Toxicity (DILIst)
Flomoxef
DILI Positive
DOI:10.1016/j.drudis.2019.09.022
Chemie und Industrie
Pharmakologische Informationen
ATC Code
J - Antiinfectives for systemic use
QJ - Antiinfectives for systemic use
Anwendungen
BeschreibungFlomoxef sodium is a P-lactamase resistant oxacephalosporin. Its spectrum of activity is similar to that of cefazolin and moxalactam, but with better efficacy against Staphylococcus aureus and Bacteroides fragilis. Flomoxef is reported effective in the treatment of post-operative, urinary tract and abdominal cavity infections.
VerwendenFlomoxef is an oxacephem derived beta-lactam antibiotic that is particularly effective against gram-positive bacteria.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Anbieter50 Anbieter
Zugehörige Reaktionen
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Verknüpfte Notizen
Wird geladen…